吸入性糖皮质激素所致气管支气管病
Tracheobronchopathy From Inhaled Corticosteroids.
作者信息
Husta Bryan C, Raoof Suhail, Erzurum Serpil, Mehta Atul C
机构信息
Lenox Hill Hospital, Hofstra Northwell School of Medicine, New York, NY.
Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
出版信息
Chest. 2017 Dec;152(6):1296-1305. doi: 10.1016/j.chest.2017.08.013. Epub 2017 Aug 31.
Abstract
Inhaled corticosteroids (ICSs) have become the mainstay of asthma control. They are also recommended as an add-on therapy to long-acting beta agonists and anticholinergics in moderate to severe COPD with recurrent exacerbations. Ultimately this clinical practice has led to the widespread use of ICSs, which are supported by a more favorable side effect profile than that of systemic steroids.
摘要
吸入性糖皮质激素（ICSs）已成为哮喘控制的主要手段。它们还被推荐作为长效β受体激动剂和抗胆碱能药物的附加治疗，用于中度至重度慢性阻塞性肺疾病（COPD）且反复加重的患者。最终，这种临床实践导致了ICSs的广泛使用，与全身用糖皮质激素相比，ICSs具有更有利的副作用谱。
相似文献
1
Tracheobronchopathy From Inhaled Corticosteroids.吸入性糖皮质激素所致气管支气管病
Chest. 2017 Dec;152(6):1296-1305. doi: 10.1016/j.chest.2017.08.013. Epub 2017 Aug 31.
2
Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.长效β2受体激动剂与安慰剂用于慢性哮喘儿童和成人并联合吸入性糖皮质激素的比较
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005535. doi: 10.1002/14651858.CD005535.
3
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.长效吸入型β受体激动剂支气管扩张剂与吸入性糖皮质激素联合使用时的安全性和有效性。
Ann Intern Med. 2006 Nov 7;145(9):692-4. doi: 10.7326/0003-4819-145-9-200611070-00012.
4
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.在未使用过类固醇的成年持续性哮喘患者中，吸入长效β2受体激动剂联合吸入性类固醇作为一线治疗方案。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD005307. doi: 10.1002/14651858.CD005307.
5
Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.维持性长效β受体激动剂与吸入性糖皮质激素对哮喘控制及哮喘急性加重的不同影响。
J Allergy Clin Immunol. 2007 Feb;119(2):344-50. doi: 10.1016/j.jaci.2006.10.043.
6
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.吸入长效β2受体激动剂与吸入性糖皮质激素联合使用与高剂量吸入性糖皮质激素治疗儿童和成人持续性哮喘的比较
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005533. doi: 10.1002/14651858.CD005533.
7
Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma.将吸入性糖皮质激素确立为哮喘抗炎首选药物的当前问题。
J Allergy Clin Immunol. 1998 Apr;101(4 Pt 2):S427-33. doi: 10.1016/s0091-6749(98)70154-x.
8
An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.吸入皮质类固醇治疗哮喘患者中长效β-激动剂的安全性更新。
Expert Opin Drug Saf. 2010 May;9(3):407-19. doi: 10.1517/14740330903535852.
9
Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.长效β受体激动剂对已接受吸入性糖皮质激素治疗的持续性哮喘患者的治疗作用
BioDrugs. 2001;15(1):11-24. doi: 10.2165/00063030-200115010-00002.
10
Use of inhaled corticosteroids in pediatric asthma.吸入性糖皮质激素在儿童哮喘中的应用。
Pediatr Pulmonol Suppl. 1997 Sep;15:27-33.
引用本文的文献
1
Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study.慢性使用吸入性皮质类固醇于因呼吸道病毒感染而住院的病患：一项六年前瞻性多中心研究。
Sci Rep. 2022 Mar 10;12(1):4199. doi: 10.1038/s41598-022-08089-0.
2
The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density.骨质疏松症和非骨质疏松症药物对骨折风险和骨密度的影响。
Drugs. 2021 Nov;81(16):1831-1858. doi: 10.1007/s40265-021-01625-8. Epub 2021 Nov 1.
3
Quality of life outcomes in tracheobronchomalacia surgery.气管支气管软化症手术的生活质量结果
J Thorac Dis. 2020 Nov;12(11):6925-6930. doi: 10.21037/jtd.2020.03.08.
4
Association between Inhaled Corticosteroids and Expiratory Central Airway Collapse in Smokers.吸烟者吸入性糖皮质激素与呼气期中央气道塌陷之间的关联。
Am J Respir Crit Care Med. 2021 Feb 15;203(4):518-521. doi: 10.1164/rccm.202008-3122LE.
本文引用的文献
1
Effect of inhaled steroids on laryngeal microflora.吸入性类固醇对喉部微生物群的影响。
Acta Otolaryngol. 2016 Jul;136(7):699-702. doi: 10.3109/00016489.2016.1146409. Epub 2016 Feb 22.
2
The role of lung transplantation in excessive dynamic collapse.肺移植在过度动态肺萎陷中的作用。
J Heart Lung Transplant. 2016 May;35(5):692-3. doi: 10.1016/j.healun.2016.01.005. Epub 2016 Jan 15.
3
Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.吸入性糖皮质激素增加慢性阻塞性肺疾病患者肺炎风险：一项全国性队列研究
Medicine (Baltimore). 2015 Oct;94(42):e1723. doi: 10.1097/MD.0000000000001723.
4
Tracheobronchial smooth muscle atrophy and separation.气管支气管平滑肌萎缩与分离。
Respiration. 2015;90(3):256-62. doi: 10.1159/000431381. Epub 2015 Jul 2.
5
Systemic effects of inhaled corticosteroids: an overview.吸入性糖皮质激素的全身效应：综述
Open Respir Med J. 2014 Dec 31;8:59-65. doi: 10.2174/1874306401408010059. eCollection 2014.
6
Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?慢性阻塞性肺疾病患者的肺炎发病率及死亡率。吸入性糖皮质激素的双重作用？
Am J Respir Crit Care Med. 2015 Jan 15;191(2):141-8. doi: 10.1164/rccm.201409-1654PP.
7
Evaluation of tracheobronchomalacia by dynamic flexible bronchoscopy. A pilot study.动态可弯曲支气管镜检查评估气管支气管软化症：一项初步研究。
Ann Am Thorac Soc. 2014 Jul;11(6):951-5. doi: 10.1513/AnnalsATS.201312-435BC.
8
Flunisolide for the treatment of asthma.氟替卡松治疗哮喘。
Expert Rev Clin Pharmacol. 2014 May;7(3):251-8. doi: 10.1586/17512433.2014.908117. Epub 2014 Apr 9.
9
Are airways structural abnormalities more frequent in children with recurrent lower respiratory tract infections?反复下呼吸道感染儿童的气道结构异常是否更常见？
Respir Med. 2014 May;108(5):800-5. doi: 10.1016/j.rmed.2014.02.014. Epub 2014 Mar 22.
10
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.吸入性糖皮质激素与慢性阻塞性肺疾病患者的肺炎风险
Cochrane Database Syst Rev. 2014 Mar 10;2014(3):CD010115. doi: 10.1002/14651858.CD010115.pub2.
Zotero 插件